fbpx

The Blog

RSV Vaccine

Matt Crist

Are you aged 60 or older?

Take part in a study assessing an investigational study vaccine to prevent respiratory syncytial virus (RSV) disease. Older adults are at an increased risk of developing serious complications, including inflammation of the lungs or pneumonia, from respiratory syncytial virus, or RSV. Insurance is not needed to participate in this study.

You may be able to take part if you:
  • are 60 years of age or older
  • are able to use smartphones, tablets, and/or computers

*Other conditions may apply

Qualified participants will receive:
  • Study-related vaccine at no cost
  • Study-related medical care at no cost
  • Compensation for time and travel

See if you qualify!

Volunteer Now

What To Expect?

Three Easy Steps

Give us a call

Step 1
FILL OUT YOUR CONTACT INFORMATION OR GIVE US A CALL

A recruiter will reach out

Step 2
A RECRUITER WILL REACH OUT SHORTLY AND ASK YOU SOME QUESTIONS

Schedule a visit

Step 3
IF YOU’RE QUALIFIED, YOU WILL BE SCHEDULED FOR AN OFFICE VISIT
About

CRCN is partnered with Wake Research, an integrated organization of premier investigational sites working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device, pharmaceutical industry and clinical research organizations in North America.